Replies to post #7177 on Biotech Values

[DewDiligence]

More on Angiosyn

#msg-5271008 (PPHM board)

>>One clinical approach to treating angiogenic vision loss, he says, could be to deliver the TrpRS molecules directly into the eye through gene- and cell-based vectors.<<

Could these molecules be eluted from a device?

p.s. Another good find, Katie.